← Leaderboards
Christine A Biron
Brown University
$9,817,840
Attributed
$9,817,840
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $971.1K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$9,817,840 · 6
By mechanism
R01$6,670,745 · 2
P20$1,700,082 · 2
R56$1,447,013 · 2
Top collaborators
No co-investigators on record.
Most similar at Brown University
Same institution · by research overlap
- Walter J Atwood$24,911,617
- Thais P. Salazar-Mather$2,135,561
- Stephen T. McGarvey$18,190,958
- Laurent Brossay$15,161,600
Others in their field
Top investigators on “Lymphocytic Choriomeningitis Virus”
- Michael B Oldstone · Scripps Research Institute$24,028,702
- Arlene H Sharpe · Harvard Medical School$19,979,288
- Elina I Zuniga · University Of California, San Diego$18,963,351
- E. John Wherry · Emory University$18,691,932
- Juan C. De La Torre · Scripps Research Institute$15,721,174
- Rama Rao Amara · Emory University$15,655,138
Research focus
Lymphocytic Choriomeningitis VirusNatural Killer CellsLaboratory MouseCytokineInterferonsTissue /Cell CultureImmune ResponseVirus DiseasesMediatingResponsePathway InteractionsInfectionAntiviral AgentsSignal TransductionVirusInsightRegulationLeukocyte Activation /TransformationCellular ImmunityShapesBetaherpesvirinaeBaseB LymphocyteGene Expression
Grant awards (28)
NK Cell STAT3 and Virus-induced IL-6 Disease$592,303
R56 · FY2016 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$441,735
R01 · FY2013 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$469,931
R01 · FY2012 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$468,737
R01 · FY2011 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$455,317
R01 · FY2010 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$457,210
R56 · FY2009 · AI · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$397,500
R56 · FY2008 · AI · contact PI
Natural Killer Cell Growth and Development$337,399
R01 · FY2008 · CA · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$365,031
R01 · FY2007 · AI · contact PI
Natural Killer Cell Growth and Development$337,399
R01 · FY2007 · CA · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$376,005
R01 · FY2006 · AI · contact PI
Natural Killer Cell Growth and Development$347,476
R01 · FY2006 · CA · contact PI
Type 1 IFN Function and Signaling in Immunity to Viruses$385,125
R01 · FY2005 · AI
Natural Killer Cell Growth and Development$355,838
R01 · FY2005 · CA
EVENTS REGULATING THE BALANCE BETWEEN RESISTANCE &INFECTION$230,109
P20 · FY2005 · RR
Type 1 IFN Function and Signaling in Immunity to Viruses$385,297
R01 · FY2004 · AI
Natural Killer Cell Growth and Development$356,029
R01 · FY2004 · CA
EVENTS REGULATING THE BALANCE BETWEEN RESISTANCE &INFECTION$287,193
P20 · FY2004 · RR
NATURAL KILLER CELL GROWTH AND DEVELOPMENT$364,016
R01 · FY2003 · CA
Type 1 IFN Function and Signaling in Immunity to Viruses$193,348
R01 · FY2003 · AI
NATURAL KILLER CELL GROWTH AND DEVELOPMENT$354,096
R01 · FY2002 · CA
Regulating the balance between resistance and infection$236,556
P20 · FY2002 · RR
Regulating the balance between resistance and infection$236,556
P20 · FY2002 · RR
NATURAL KILLER CELL GROWTH AND DEVELOPMENT$343,993
R01 · FY2001 · CA
Regulating the balance between resistance and infection$236,556
P20 · FY2001 · RR
Regulating the balance between resistance and infection$236,556
P20 · FY2001 · RR
NATURAL KILLER CELL GROWTH AND DEVELOPMENT$333,973
R01 · FY2000 · CA
Regulating the balance between resistance and infection$236,556
P20 · FY2000 · RR